Rubella

Generalities
Agent	Rubella virus, genus Rubullovirus, family Togaviridae
Incubation period	14-17 days (range 14-21 days)
Period of transmissibility	- 7 days before rash and 4 days after rash onset - From congenital rubella: infants shed the virus for several months after birth
Reservoir	Humans
Modes of transmission	- Person-to-person: direct contact with droplets - Infants with Congenital Rubella Syndrome shed large quantities of virus in their pharyngeal secretions and urine. - Materno-foetal transmission: 90% of infants born to women infected with rubella during the 1st trimester. The risk of transmission is 10-20% by the 16th week, and rare after the 20th week.
Clinical presentation	- Febril maculo-papular rash - Complications: thrombocytopenia (1/3000), post-infectious encephalitis (1/6000), rarely chronic arthritis - Congenital Rubella Syndrome: Congenital malformation as deafness, cataracts, microphtalmia, congenital glaucoma, pigmentary retinopathy, nystagmus, microcephaly, meningo-encephalitis, mental retardation, patent ductus arteious, atrial or ventricular septal defects, other congenital heart disease, purpura, hepatosplenomegaly, jaundice, radiolucent bone disease
Resources
Case definitions	- MOPH circular no 12 (2013): Acquired Rubella - MOPH circular no 45 (2007): Congenital Rubella Syndrome
Forms	- Rash reporting form - CRS reporting form - Rash investigation form - CRS investigation form
Data	- Rubella 2021 - Rubella 2020 - Rubella 2019 - Rubella 2018 - Rubella 2017 - Rubella 2016 - Rubella 2015

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
L01BC02	5-FLUOROURACIL EBEWE	G	Fluorouracil - 1000mg/20ml	1000mg/20ml	Injectable concentrated solution	653,107 L.L
N01BB02	? 2% LIDOCAINE HCL USP	G	Lidocaine HCl - 2%	2%	Injectable solution	255,970 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
M01AE01	? IBUPROFEN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	383,955 L.L
P01AB01	? METRONIDAZOL	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L
C01CA03	? NORADRENALINE	G	Norepinephrine tartrate - 8mg/4ml	8mg/4ml	Injectable solution	330,201 L.L
A04AA01	? ONDANSETRON USP	G	Ondansetron - 8mg/4ml	8mg/4ml	Injectable solution	447,948 L.L
N02BE01	? PARACETAMOL	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	191,978 L.L
N03AB02	? PHENYTOIN SODIUM 5% USP	G	Phenytoin (sodium) - 250mg/5ml	5ml	Injectable solution	276,448 L.L
D10BA01	A-CNOTREN	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,468,376 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
N02BE51	A.B.C.-COLD	G	Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg		Tablet, film coated	534,977 L.L
B01AC06	A.S HEART	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
N05AX12	ABIPREX 10	G	Aripiprazole - 10mg	10mg	Tablet	1,075,074 L.L
N05AX12	ABIPREX 15	G	Aripiprazole - 15mg	15mg	Tablet	1,075,074 L.L
L02BX03	ABIRATERONE ACETATE NEAPOLIS	G	Abiraterone acetate - 250mg	250mg	Tablet	75,418,662 L.L
L02BX03	ABIRATERONE ACETATE SPC	G	Abiraterone acetate - 250mg	250mg	Tablet, film coated	92,278,660 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	45,056,853 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	45,056,853 L.L